vimarsana.com

Page 5 - அலுவலகம் ஆஃப் தொழில்நுட்பம் வணிகமயமாக்கல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Dead lithium batteries pulled from hard disk drives, electric vehicles could find new life through process that recycles critical rare-earth elements

May 6, 2021 Dead lithium batteries pulled from hard disk drives, electric vehicles could find new life through process that recycles critical rare-earth elements American Resources Corp. and Purdue University have teamed to advance an environmentally safer method that recycles rare-earth metals to advance clean energy electronic technologies used in hard disk drives, electric vehicles, wind turbines and other electronics. (Illustration provided by Linda Wang) FISHERS, Ind. – American Resources Corp., a socially responsible supplier of high-quality raw materials, (NASDAQ:AREC) announced Thursday (May 6) an expansion of its existing sponsored research program with Purdue University. The agreement will focus on advancing the purification of critical and rare-earth elements (“REEs”).  The partnership builds on a previous agreement to advance a Purdue-developed technology to refine rare-earth elements purification technology to recycle permanent magnets and lithium-ion batte

UAH - News

University of North Carolina at Chapel Hill: Breakthrough gene therapies in sight

Share Patients with genetic lysosomal storage diseases – particularly children – are living longer because of better treatments. But with promising advances and longer lives comes complications, the loss of eyesight as these rare diseases take their toll over time. Lysosomal storage diseases are inherited metabolic diseases that are characterized by an abnormal build-up of various toxic materials in the body’s cells as a result of enzyme deficiencies, according to the National Organization for Rare Disorders. With these diseases, patients are missing the mucopolysaccharidosis type 1 (MPS1) gene. Current therapies that allow patients to live longer don’t address corneal clouding caused by these diseases. However, one Carolina-affiliated startup, RainBio, is developing a novel gene therapy for MPSI corneal blindness, giving patients a chance not only for longer lives but better ones.

Purdue selected for new fund to grow rural communities

MORE WEST LAFAYETTE, IN. – Purdue University has been hand-picked by Big Idea Ventures LLC, a global leader in early-stage food technology and alternative protein investment, for a new fund to commercialize university intellectual property. The new Generation Food Rural Partners (GFRP) fund is a $125 million target fund that will fuel economic development in rural communities across the United States through the commercialization of food and agricultural technologies, protein innovation and other university intellectual property. “We are proud to join a select group of universities for this new opportunity focused on commercialization, higher education and rural economies,” said Wade Lange, vice president and chief entrepreneurial officer of the Purdue Research Foundation. “Purdue has a strong network of innovators focused on technologies to provide food and agricultural solutions.”

Breakthrough gene therapies in sight | UNC-Chapel Hill

Patients with genetic lysosomal storage diseases – particularly children – are living longer because of better treatments. But with promising advances and longer lives comes complications, the loss of eyesight as these rare diseases take their toll over time. Lysosomal storage diseases are inherited metabolic diseases that are characterized by an abnormal build-up of various toxic materials in the body’s cells as a result of enzyme deficiencies, according to the National Organization for Rare Disorders. With these diseases, patients are missing the mucopolysaccharidosis type 1 (MPS1) gene. Current therapies that allow patients to live longer don’t address corneal clouding caused by these diseases. However, one Carolina-affiliated startup, RainBio, is developing a novel gene therapy for MPSI corneal blindness, giving patients a chance not only for longer lives but better ones.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.